Technical question; Equity Risk Premium for a company operating overseas.

Hi I have a question for today.

The question is about which ERP I should use for a complicated company.

In Korea, there is a company named Coupang whose 100% of revenue is from Korea, which means they record revenue by KRW, not $. 

The thing is that this company is listed on Nasdaq

According to Damodaran, the risk-free rate should be aligned with the currency the company earns, so in this case I used 10yrs Korean government bond. 

But I can't determine which ERP I should use for this company, the expected return of Korean market index or of Nasdaq. 

My thought was as follows:

"I'm now calculating the cost of equity, which will be used to discount the cash flow in coming years, so I think I should use the expected return of Korean market index aligning with the currency this company is earning and also because they are operating their business in Korea. The Korean market index reflects the economy of Korea which the company is having business in. Oh wait, but we now want "an expected return of average equity," and this company is listed on Nasdaq, which means the majority of Coupang's investors would pay attention to Nasdaq, not Korean index, so the stock price of this company would be more likely to be aligned with Nasdaq..? And considering that we have to attach beta, the connection between the stock's return and market, to this ERP, do I have to use the expected return of Nasdaq?"

Very complicated. In terms of the relationship between location where the business is operated and the financial market, seems like Korean market index, but from the investor's view, seems like Nasdaq is the right answer. 

Appreciate any opinions. I'd be happy to discuss this.

Thank you.

 

Thanks for your comment!

Btw, could you elaborate on the situation where I would convert figures for valuation and comps? 

I can't think of a situation where I use WACC in the process of comps.

And what kind of figures can I covert to fit the Nasdaq? 

Thanks again.

 
Most Helpful

i just can't justify valuing the rest of the company using korean metrics, then using the nasdaq as the ERP. Just doesn't sit well with me. There would run some problems of american companies running idiosyncratic bets, then if u used nasdaq as the ERP, Coupang might look cheap to you. Just a random example.

Top tip: Coupang is a very well-covered company by analysts, you could defo just dig up some coverage and find the premium attached to the company

As for conversion to fit Nasdaq companies, some examples would include converting accounting figures (korean comps report differently than nasdaq, and i 100% bet u'd need to convert to GAAP anyway), adjusting EV/ EBITDA to reflect different tax rates and D&A, experimenting with diff multiples to better fit your sample group in the Nasdaq. I'm not sure of any good direct comparables on the Nasdaq to reflect the geography tbh

And as for WACC, true haha u dont rlly use WACC for comps. I see you're an Aswath fan, you'll know he HATES people who mess up intrinsic and relative valuation, and just ascribe a multiple for their TV for their 'intrinsic valuation'. If anyone is using a multiple for their TV, that's relative valuation not intrinsic. But then that's Aswath's personal style

 

Repudiandae ad accusantium est nulla. Tempora neque dolores corporis. Et tenetur sunt dolor laudantium.

Reprehenderit nihil adipisci exercitationem animi minus necessitatibus qui. Assumenda beatae minima sint dolorem. Occaecati quis distinctio aut soluta dignissimos unde omnis.

Ratione est omnis consequatur et omnis vitae et. Eius quas et et voluptas labore dolore nam. Dignissimos eos deleniti odit eum eius consequatur. Harum ea expedita architecto ad sed alias sunt. Aliquam aliquam omnis non enim esse error repellendus.

Possimus in quasi voluptatem qui facilis quia id id. Et voluptatem libero consectetur. Accusantium corrupti aut aut aut maiores quisquam repellat. Architecto in optio quo rerum aperiam commodi. Recusandae quas fuga quisquam quo totam qui. Commodi optio voluptas quod tenetur.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Perella Weinberg Partners New 98.9%
  • Lazard Freres 01 98.3%
  • Harris Williams & Co. 24 97.7%
  • Goldman Sachs 16 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.9%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 05 97.7%
  • Perella Weinberg Partners New 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.9%
  • Perella Weinberg Partners 18 98.3%
  • Goldman Sachs 16 97.7%
  • Moelis & Company 06 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (206) $159
  • Intern/Summer Analyst (148) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”